{"id":"meptin-swinghaler","safety":{"commonSideEffects":[{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Palpitations"},{"rate":null,"effect":"Nervousness"},{"rate":null,"effect":"Muscle cramps"}]},"_chembl":{"chemblId":"CHEMBL160519","moleculeType":"Small molecule","molecularWeight":"290.36"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug binds to beta-2 adrenergic receptors on airway smooth muscle cells, triggering intracellular signaling that leads to muscle relaxation and bronchodilation. This increases airway diameter and improves airflow, providing symptomatic relief in obstructive airway diseases. The Swinghaler formulation is an inhalation device designed for convenient drug delivery.","oneSentence":"Meptin is a beta-2 adrenergic agonist that relaxes airway smooth muscle to improve breathing in respiratory conditions.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:20:45.814Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma"},{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT01095016","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients","status":"COMPLETED","sponsor":"Taiwan Otsuka Pharm. Co., Ltd","startDate":"2010-03","conditions":"Asthma","enrollment":32},{"nctId":"NCT01076322","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients","status":"COMPLETED","sponsor":"Taiwan Otsuka Pharm. Co., Ltd","startDate":"2009-03","conditions":"Asthma","enrollment":17}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Meptin® Swinghaler®","Procaterol HCL","Ventolin® MDI","Salbutamol sulfate"],"phase":"phase_3","status":"active","brandName":"Meptin® Swinghaler","genericName":"Meptin® Swinghaler","companyName":"Taiwan Otsuka Pharm. Co., Ltd","companyId":"taiwan-otsuka-pharm-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Meptin is a beta-2 adrenergic agonist that relaxes airway smooth muscle to improve breathing in respiratory conditions. Used for Asthma, Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}